Using FISH to Detect Cancer Cells in Breast Effusions
Author Information
Author(s): N Zojerl, M FiegIl, J Angerlerl, L Mullauer, A Gsurl, S Rokal, M Pecherstorfer, H Huber, J Drach
Primary Institution: University of Vienna
Hypothesis
Can fluorescence in situ hybridization (FISH) improve the detection of malignant cells in effusions from breast cancer patients?
Conclusion
FISH is a valuable tool for diagnosing malignancy in breast cancer effusions, significantly improving detection rates compared to routine cytology.
Supporting Evidence
- Routine cytology identified malignancy in 60% of effusions.
- FISH detected aneuploid cell populations in 94% of cytologically positive effusions.
- FISH revealed true aneuploidy in 48% of cytologically negative effusions.
Takeaway
Scientists used a special test called FISH to find cancer cells in fluid from breast cancer patients, and it worked much better than the usual tests.
Methodology
The study evaluated 57 effusion samples from breast cancer patients using routine cytology and FISH with specific chromosome probes.
Limitations
The study may not account for all types of non-malignant effusions and relies on specific cut-off levels for aneuploidy.
Participant Demographics
41 breast cancer patients aged 41 to 85 years, median age 58.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website